Phosphoramidate alkylator prodrugs
US8507464B2 · kind B2 · utility
8Cited by
31References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 17, 2011 |
| Grant date | Aug 13, 2013 |
| Priority date | — |
| Expiry date | Jun 17, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.